World

Elon Musk Highlights New Appetite Inhibiting Drugs As Solution To US Obesity Crisis

Elon Musk has suggested that emerging appetite-inhibiting medications could significantly address the rising obesity rates in the United States.

Obesity rates will plummet with new appetite-inhibiting drugs, says Musk

Responding to a user’s comment about the alarming obesity statistics on social media platform X, Musk expressed optimism about new pharmaceutical interventions.

“40 percent of Americans are obese,” the user pointed out, referencing data from the Organisation for Economic Co-operation and Development (OECD) from 2018.

Musk’s response was unequivocal, “They will plummet with the new appetite-inhibiting drugs.”

Obesity, a condition marked by excessive body fat, poses serious health risks and contributes significantly to the nation’s healthcare burden.

The US Centers for Disease Control and Prevention (CDC) reports that more than 40% of American adults are classified as obese.

The World Health Organization (WHO) however defines obesity as a body mass index (BMI) of 30 or higher and considers a BMI of 25 and above as overweight.

The condition can lead to severe health issues, including diabetes, hypertension, and various cancers.

Globally, obesity is a growing concern.

In 2022, the WHO estimated that 1 in 8 people worldwide lived with obesity, with over 390 million children and adolescents aged 5-9 years being overweight, including 160 million classified as obese.

Recent advancements in weight management have seen the introduction of Semaglutide, a drug marketed as Ozempic and Wegovy by Novo Nordisk.

Developers initially created Semaglutide for type 2 diabetes and later repurposed it for weight loss.

The drug mimics the hormone glucagon-like peptide 1 (GLP-1), which is naturally released after eating.

By activating GLP-1 receptors, Semaglutide reduces appetite and promotes feelings of fullness.

In 2023, Musk revealed that he lost approximately 20 pounds using Wegovy combined with intermittent fasting, which involves eating within restricted time windows.

This drug offers an alternative to more invasive weight loss surgeries and has shown promise in managing obesity.

Also Read: India, US Forge Security Of Supply Agreement To Strengthen Defense Cooperation

Mankrit Kaur

Recent Posts

PM Modi To Inaugurate Bihar’s Nitish Setu On November 21, Boosting Regional Connectivity

The much-awaited Kacchi Dargah-Bidupur Six-Lane Ganga Bridge, known as Nitish Setu, is ready for inauguration…

54 mins ago

Bihar Chhath Puja 2026: Extensive Arrangements Ensure Peaceful Celebrations Across State

Bihar concluded Chhath Puja 2026 peacefully with extensive security, sanitation and infrastructure arrangements across thousands…

1 hour ago

Ex-Muslim Sahil Alleges Attack By 12 People In Navi Mumbai, Claims He Was Targeted Over His Views On Islam

Social media personality Ex-Muslim Sahil claimed that a group attacked him in Vashi, Navi Mumbai,…

1 hour ago

Trump Calls PM Modi A ‘Very Tough Man’ After Quad Leaders’ Meeting In Manila

US President Donald Trump praised Prime Minister Narendra Modi as a 'very tough man' following…

3 hours ago

PM Modi, Thailand PM Anutin Charnvirakul Review Strategic Partnership At Manila Summit

Prime Minister Modi met his Thai counterpart Anutin Charnvirakul in Manila to review bilateral ties…

3 hours ago

Indian Stock Markets Rally Further As Nifty Reclaims Nine-Month Peak And Bank Nifty Sets Record

Indian benchmark indices ended higher on Tuesday, with the Sensex rising 427 points and the…

3 hours ago